The use of monoclonal antibody stains in Mohs micrographic surgery

Australasian Journal of Dermatology

Volumn 38, Issue 1, 1997, Pages 44-45

  Salmon, Robert M ^a,b  

^a Illawarra Dermatology Associates   (Australia)

^b Illawarra Area Health Service   (Australia)

Author keywords

cytokeratin; dermatofibrosarcoma protruberans; extramammary Paget's disease; immunohistochemical techniques; immunoperoxidase; lentigo maligna; morphoeic basal cell carcinoma; perineural squamous cell carcinoma

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY;

BASAL CELL CARCINOMA; CHEMOSURGERY; DERMATOFIBROSARCOMA PROTUBERANS; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MALIGNANT LENTIGO; PAGET SKIN DISEASE; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

EID: 0030986148     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1997.tb01101.x     Document Type: Short Survey

References (5)

1. Robinson JK. Margin control for lentigo maligna. J. Am. Acad. Dermatol. 1994; 51: 79-85.
2. Jiminez FJ, Grichnik JM, Buchanan MD, Clark RE. Immunohistochemical techniques in Mohs micrographic surgery: Their potential use in the detection of neoplastic cells masked by inflammation. J. Am. Acad. Dermatol. 1995; 32: 89-94.
3. Zachary CB, Rest EB, Furlong SM et al. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J. Dermatol. Surg. Oncol. 1994; 20: 530-5.
4. Ramnarian D, Walker NPJ. Rapid immunoperoxidase and immunofluorescence techniques using cytokeratin markers to assist in the diagnosis of basal cell carcinoma in Mohs micrographic surgery. Br. J. Dermatol. 1991; 115 (Suppl.): S38.
5. Tellechea O, Reis JP, Domingues JC, Baptista JP. Monoclonal antibody Ber EP4 distinguishes basal cell carcinoma from squamous cell carcinoma of the skin. Am. J. Dermatopathol. 1993; 15: 452-5.